According to Stratview Research, the liquid biopsy market was estimated at USD 2.83 billion in 2022 and is likely to grow at a CAGR of 17.99% during 2023-2028 to reach USD 7.64 billion in 2028. In the realm of modern medicine, the quest for non-invasive diagnostic tools that offer accurate and timely insights into disease has long been a holy grail. Enter...